Introducing our Board of Directors who offer a wealth of expertise, knowledge and talent to our organization.
Introducing our Board of Directors who offer a wealth of expertise, knowledge and talent to our organization.
Chair of the Board
Born 1967
MBA from Copenhagen Business School, Denmark.
Extensive experience from the pharmaceutical industry and in medical technology. Former CEO of the Danish hearing aid company GN Hearing, President and CEO of Danish pharmaceutical company Leo Pharma. Chair of the GN Foundation and Member of the Boards of ALK-ABELLÓ A/S, Union Therapeutics A/S, Danish Chamber of Commerce. Board member of Dynavox Group since 2024.
Independent in relation to:
The company and executive management: Yes
Major Shareholders: Yes
Board member
Born 1966
MSc in Business Administration, Lund University, Sweden.
Extensive experience from leading positions in IT and telecom, e.g. COO at Axis, CEO at Decuma and TAT. Chairman of the Board of Skåne Startups. Board member of Invisio, Net Insight, Bure Equity, Boule Diagnostics, Nel ASA and the Malmö-based incubator Minc. Previously member of the board of directors at companies such as Axis, Doro and Sinch. Board member of Tobii since 2018. Board member of Dynavox Group since 2021.
Independent in relation to:
The company and executive management: Yes
Major Shareholders: Yes
Shareholding, own and close related: none common shares in the Company.
Board member
Born 1974
MSc in Industrial Engineering & Management, International Profile, Linköping University, Sweden.
Co-founder and CEO of Tobii from 2001-2021. Board member of Dynavox Group since 2021.
Independent in relation to:
The company and executive management: No
Major Shareholders: Yes
Board member
Born 1977
Ph.D. in neuroscience and lecturer at the Karolinska Institutet, Sweden.
Specialist and senior physician in neurology and neuromuscular diseases. Founder and director of the Karolinska ALS Center. Founder and director of the national ALS registry in Sweden, as well as the Karolinska ALS Treatment Center, which focuses on clinical trials for ALS. Board member of TRICALS and holds several scientific board positions in ALS-related organizations, including pharmaceutical companies. Board member of Dynavox Group since 2021.
Independent in relation to:
The company and executive management: Yes
Major Shareholders: Yes
Board member
Born 1974
MBA from INSEAD and MSc in Chemical Engineering from Chalmers University of Technology, Sweden.
Deputy CEO and CFO of the listed Profoto AB. Former CFO of the assistive technology company Permobil Group, CFO of the listed real estate developer JM AB and management consultant at Boston Consulting Group and Accenture. Board member of Dynavox Group since 2021.
Independent in relation to:
The company and executive management: Yes
Major Shareholders: Yes
Board member
Born 1967
Ph.D. in Physics, University of Leiden, The Netherlands
Extensive experience from senior leadership positions in consumer and professional healthcare businesses in Europe, e.g. President OTC hearing aid business and CMO at WSA Group, Chief Executive Officer and Board member at Euro-Diesel S.A. General Manager of Philips MRI Systems at Philips Healthcare, CEO Connected Care and CTO Consumer Healthcare Solutions at Philips Consumer Healthcare. Board member of Dynavox Group since 2023.
Independent in relation to:
The company and executive management: Yes
Major Shareholders: Yes
You will receive an email to verify your email address and activate the subscription. You may close this dialog.
We could not save your subscription. Please close this dialog and try again.